Nyxoah SA Logo

Nyxoah SA

NYXH | BR

Overview

Corporate Details

ISIN(s):
BE0974358906
LEI:
5493002O1ESKZ18OXR80
Country:
Belgium
Address:
Rue Edouard Belin 12, 1435 Mont-Saint-Guibert
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Nyxoah SA is a commercial-stage medical technology company focused on the development and commercialization of innovative solutions for Obstructive Sleep Apnea (OSA). The company's lead product is the Genio® system, an implantable neurostimulation therapy designed to treat patients with moderate to severe OSA. The system works by providing bilateral stimulation to the hypoglossal nerve, which controls the tongue muscles, thereby keeping the airway open during sleep. It is intended as a therapeutic alternative for patients who cannot tolerate or have failed traditional Continuous Positive Airway Pressure (CPAP) therapy.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Nyxoah SA. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-18 22:10
Earnings Release
ENGLISH_Q2 2025 Earnings PR_FINAL.pdf
English 316.1 KB
2025-08-18 22:10
Earnings Release
FRENCH_Q2 2025 Earnings PR_FINAL.pdf
French 310.1 KB
2025-08-18 22:10
Interim Report
Q2 2025 financial report (Euronext) (ENG) (final).pdf
English 800.2 KB
2025-08-18 22:10
Interim Report
Q2 2025 financial report (Euronext) (FR) (final).pdf
French 803.6 KB
2025-08-18 22:10
Earnings Release
Nyxoah Reports Second Quarter Financial and Operating Results
English 55.6 KB
2025-08-11 07:00
Earnings Release
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
English 14.8 KB
2025-08-08 23:30
Regulatory News Service
Nyxoah Receives Approval from FDA for Genio System for the Treatment of Obstruc…
English 12.9 KB
2025-08-08 22:10
Regulatory News Service
ENGLISH_FDA APPROVAL PRESS RELEASE - FINAL.pdf
English 156.0 KB
2025-08-08 22:10
Regulatory News Service
FRENCH_FDA APPROVAL PRESS RELEASE - FINAL.pdf
French 166.1 KB
2025-07-29 22:45
Declaration of Voting Results & Voting Rights Announcements
2025 07 29 - Press release - Number of shares (ENG).pdf
English 136.6 KB
2025-07-29 22:45
Declaration of Voting Results & Voting Rights Announcements
2025 07 29 - Press release - Number of shares (FR).pdf
French 136.0 KB
2025-07-28 22:05
Legal Proceedings Report
Nyxoahs DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Med…
English 14.7 KB
2025-07-02 14:00
Post-Annual General Meeting Information
Nyxoah - Second ESM 2025 - Resolutions - ENG.pdf
English 206.9 KB
2025-07-02 14:00
Post-Annual General Meeting Information
Nyxoah - Second ESM 2025 - Notarial deed - FR (signed).pdf
French 426.0 KB
2025-06-13 07:00
Pre-Annual General Meeting Information
DOC 24 - Nyxoah - Second ESM 2025 - Proxy form - ENG FR.pdf
French 276.6 KB

Automate Your Workflow. Get a real-time feed of all Nyxoah SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Nyxoah SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-19 Laurette Renard Close relation Sell 5,000 39,000.00 EUR
2024-09-05 Hambrecht Jürgen Board Sell 980,000 6,840,400.00 EUR
2024-09-05 JH Capital GmbH Close relation Buy 980,000 6,840,400.00 EUR
2024-01-25 Tompkins Patrick Executive member Buy 2,000 18,020.00 USD
2023-12-28 Onkelinx Bruno Executive member Buy 470 2,035.10 EUR
2023-08-18 Moreau Loïc Executive member Buy 6,427 48,416.52 EUR
2023-08-14 Moreau Loïc Executive member Buy 3,800 28,697.60 EUR
2023-08-11 Moreau Loïc Executive member Buy 3,000 21,957.60 EUR
2023-07-04 Wildman Ventures LLC Board Buy 25,000 N/A
2023-07-02 Gianello Pierre Board Buy 25,000 N/A

Peer Companies

Company Country Ticker View
Acarix Logo
AI-powered acoustic system for rapid, non-invasive rule-out of Coronary Artery Disease.
Sweden ACARIX
Develops a pain-free breath device to measure blood glucose for diabetes management.
Poland AME
Arcoma AB Logo
Develops and manufactures advanced digital X-ray and radiology solutions for global healthcare.
Sweden ARCOMA
Develops software & hardware for precise surgical navigation and radiation therapy.
Germany N/A
Brainsway Ltd. Logo
Develops noninvasive Deep TMS therapy for depression, OCD, and smoking cessation.
Israel BWAY
Clinical Laserthermia Systems AB Logo
Develops image-guided laser ablation systems for urology and neurosurgery applications.
Sweden CLS
Cm International Spolka Akcyjna Logo
Designs & manufactures electronics for medical, aesthetic, and home appliance industries.
Poland CMI
Comet Holding AG Logo
Develops RF power and x-ray systems for semiconductor, electronics, auto, and aerospace industries.
Switzerland COTN
DELTEX MEDICAL GROUP PLC Logo
Develops Oesophageal Doppler Monitors for real-time blood flow data in surgery & critical care.
United Kingdom DEMG
Detection Technology Oyj Logo
Global provider of X-ray detector solutions for medical, security, and industrial applications.
Finland DETEC